Dr. William Edward Sheffield Jr., MD Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 32 Turkey Canyon Road, Carlsbad, NM 88220 Phone: 575-981-2486 Fax: 505-216-9886 |
Donald Walter Malone, M.D. Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2402 W. Pierce St., Suite 6e, Carlsbad, NM 88220 Phone: 575-628-0312 Fax: 575-628-8015 |
Titus Plomaritis Jr., M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2402 W Pierce St Ste 6e, Carlsbad, NM 88220 Phone: 575-628-3012 Fax: 575-628-8015 |
News Archive
In a Perspective in the April 12, 2007 issue of The New England Journal of Medicine (NEJM) , researchers from the Harvard School of Public Health (HSPH) and the Association of European Cancer Leagues describe the growing momentum for indoor smoking bans in countries across the globe.
BIOBASE, a leading provider of biological databases and software for the life sciences industry, announced today the renewal of the second year of a 5-year licensing agreement with the National Institutes of Health (NIH). This 5-year contract provides all 27 NIH institutions with locally installed access to the BIOBASE Knowledge Library™ which includes the premier TRANSFAC® and PROTEOME® databases.
The New York Times: "[E]ight months into the new law there is a growing frenzy of mergers involving hospitals, clinics and doctor groups eager to share costs and savings, and cash in on the incentives [provided in the overhaul]. They, in turn, have deployed a small army of lawyers and lobbyists trying to persuade the Obama administration to relax or waive a body of older laws intended to thwart health care monopolies, and to protect against shoddy care and fraudulent billing of patients or Medicare.
OVER-45s are at a higher risk of contracting STIs than ever before because of society's unwillingness to talk about middle-aged and older people having sex, a new report has found.
A.P. Pharma, Inc. has announced that it has submitted a New Drug Application (NDA) for its lead product, APF530, to the U.S. Food and Drug Administration (FDA). APF530 is being developed for the prevention of chemotherapy-induced nausea and vomiting (CINV) and is a long-acting formulation of granisetron that utilizes the Company's proprietary Biochronomer drug delivery system.
› Verified 5 days ago